首页> 外文期刊>Acta biomaterialia >Hemolytic properties of synthetic nano- and porous silica particles: The effect of surface properties and the protection by the plasma corona
【24h】

Hemolytic properties of synthetic nano- and porous silica particles: The effect of surface properties and the protection by the plasma corona

机译:合成纳米和多孔二氧化硅颗粒的溶血特性:表面特性的影响和等离子体电晕的保护

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Novel silica materials incorporating nanotechnology are promising materials for biomedical applications, but their novel properties may also bring unforeseen behavior in biological systems. Micro-size silica is well documented to induce hemolysis, but little is known about the hemolytic activities of nanostructured silica materials. In this study, the hemolytic properties of synthetic amorphous silica nanoparticles with primary sizes of 7-14 nm (hydrophilic vs. hydrophobic), 5-15 nm, 20 nm and 50 nm, and model meso/macroporous silica particles with pore diameters of 40 nm and 170 nm are investigated. A crystalline silica sample (0.5-10 μm) is included for benchmarking purposes. Special emphasis is given to investigations of how the temperature and solution complexity (solvent, plasma), as well as the physicochemical properties (such as size, surface charge, hydrophobicity and other surface properties), link to the hemolytic activities of these particles. Results suggests the potential importance of small size and large external surface area, as well as surface charge/structure, in the hemolysis of silica particles. Furthermore, a significant correlation is observed between the hemolytic profile of red blood cells and the cytotoxicity profile of human promyelocytic leukemia cells (HL-60) induced by nano- and porous silica particles, suggesting a potential universal mechanism of action. Importantly, the results generated suggest that the protective effect of plasma towards silica nanoparticle-induced hemolysis as well as cytotoxicity is primarily due to the protein/lipid layer shielding the silica particle surface. These results will assist the rational design of hemocompatible silica particles for biomedical applications.
机译:结合纳米技术的新型二氧化硅材料是用于生物医学应用的有前途的材料,但它们的新颖性质也可能在生物系统中带来无法预料的行为。微米级二氧化硅可导致溶血,但对纳米结构二氧化硅材料的溶血活性知之甚少。在这项研究中,主要尺寸为7-14 nm(亲水性与疏水性),5-15 nm,20 nm和50 nm的合成无定形二氧化硅纳米颗粒的溶血特性,并模拟孔径为40的中/大分子二氧化硅颗粒研究了nm和170 nm。包括结晶二氧化硅样品(0.5-10μm)用于基准测试。特别强调研究温度和溶液的复杂性(溶剂,等离子体)以及理化特性(例如大小,表面电荷,疏水性和其他表面特性)如何与这些颗粒的溶血活性相关联。结果表明,在二氧化硅颗粒的溶血中,小尺寸和大表面积以及表面电荷/结构的潜在重要性。此外,观察到红细胞的溶血特性与纳米和多孔二氧化硅颗粒诱导的人早幼粒细胞白血病细胞(HL-60)的细胞毒性特性之间存在显着相关性,表明潜在的通用作用机理。重要的是,产生的结果表明血浆对二氧化硅纳米颗粒诱导的溶血的保护作用以及细胞毒性主要是由于蛋白质/脂质层屏蔽了二氧化硅颗粒表面。这些结果将有助于为生物医学应用合理设计血液相容性二氧化硅颗粒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号